Skip to content

Prediction of the Risks of Cardiovascular Mortality

Prediction of the Risks of Cardiovascular Mortality

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06103448
Enrollment
200
Registered
2023-10-26
Start date
2024-01-31
Completion date
2024-12-31
Last updated
2023-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Cardiovascular Diseases, Cardiovascular Morbidity, Embolism, Stroke

Keywords

ankle-brachial index, cardiovascular mortality, prevention

Brief summary

Monitoring risks of cardiovascular diseases in working population (18 - 65 years old) by monitoring their BMI, ankle-brachial index with pulse wave velocity, cholesterol and glycemia.

Detailed description

Monitoring working population in their workplace by measuring their ankle-brachial index with pulse wave velocity, BMI, glycemia and cholesterol. Putting acquired data in correlation to their work habits, type of employment, work demands, job type, activity levels. Trying to find common predictors of cardiovascular disease. All assessed subjects must understand written and spoken Czech, must be employed in a company that consents with our data collections, must be older than 18 year old, doesn't have any bleeding disorder, doesn't have deep vein thrombosis (as it produces inaccurate data with ankle brachial index). Study will be conducted in Ustecky Region in the Czech Republic on approximately 200 subjects.

Interventions

DEVICEAnkle-brachial index - system 100

Measurement of ankle brachial index on all four limbs, drawing three blood drops for point of care (POC) cholesterol meter and one drop of blood for POC glucometer

Sponsors

Jan Evangelista Purkyne University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* employed in Ustecky Region Czech Republic * adult * understands spoken and written Czech * consents with assessment * works in a company that consents to assessments of their employees

Exclusion criteria

* deep vein thrombosis * not currently employed * on sick leave * bleeding disorder

Design outcomes

Primary

MeasureTime frameDescription
Body composition3 minutesUsing body composition scale the following markers will be counted: bone mass, body fat, muscle mass, water levels. All results will be in %
Height1 minutemeasured by tailor tape measure (m)
Detection of glycemia, HDL, LDL and triacylglyceride levels5 minutesGlycemia, HDL, LDL and triacylglyceride levels (mmol/l) will be measured from drops of blood by point-of-care analysers
Weight1 minutemeasured by body composition scale (kg)
Ankle-brachial index2 minutesAnkle-brachial index (no unit) using ABI-system-100 will be counted from blood pressure measured in all four limbs (mmHg)
Ankle brachial pulse wave velocity (baPWV) and carotid femoral pulse wave velocity (cfPWV)2 minutesbaPWV and cfPWV will be measure by ABI-system-100 (m/s)

Secondary

MeasureTime frameDescription
BMI2 minutesBMI (kg/m\^2) will be counted from weight (kg) and height (m)

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026